Eli Lilly and Company
LLY
$726.31
-$19.64-2.63%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.04B | 2.62B | 2.94B | 3.72B | 2.44B |
Total Receivables | 11.09B | 10.10B | 9.03B | 8.90B | 8.30B |
Inventory | 5.77B | 4.90B | 4.80B | 4.54B | 4.31B |
Prepaid Expenses | 5.54B | 5.25B | 4.53B | 3.58B | 2.95B |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 279.10M | 138.90M | 32.60M | 64.60M | 33.90M |
Total Current Assets | 25.73B | 23.01B | 21.33B | 20.81B | 18.03B |
|
|||||
Total Current Assets | 25.73B | 23.01B | 21.33B | 20.81B | 18.03B |
Net Property, Plant & Equipment | 12.91B | 11.86B | 11.28B | 10.55B | 10.14B |
Long-term Investments | 4.94B | 4.09B | 4.08B | 4.07B | 4.07B |
Goodwill | 4.94B | 4.09B | 4.08B | 4.07B | 4.07B |
Total Other Intangibles | 6.91B | 6.78B | 6.90B | 7.09B | 7.21B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.11B | 9.11B | 8.19B | 7.61B | 6.83B |
Total Assets | 64.01B | 57.92B | 54.81B | 53.16B | 49.49B |
|
|||||
Total Accounts Payable | 2.60B | 2.44B | 2.47B | 2.02B | 1.93B |
Total Accrued Expenses | 13.42B | 12.76B | 11.26B | 10.27B | 9.92B |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 7.13B | 2.25B | 670.30M | 13.00M | 1.50B |
Total Finance Division Other Current Liabilities | 4.14B | 4.56B | 4.51B | 3.71B | 3.78B |
Total Other Current Liabilities | 4.14B | 4.56B | 4.51B | 3.71B | 3.78B |
Total Current Liabilities | 27.29B | 22.00B | 18.92B | 16.01B | 17.14B |
|
|||||
Total Current Liabilities | 27.29B | 22.00B | 18.92B | 16.01B | 17.14B |
Long-Term Debt | 18.42B | 18.08B | 18.28B | 18.97B | 14.87B |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 910.40M | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 6.51B | 6.53B | 6.47B | 6.89B | 6.70B |
Total Liabilities | 53.14B | 46.61B | 43.66B | 41.87B | 38.71B |
|
|||||
Common Stock & APIC | 7.84B | 7.75B | 7.54B | 7.39B | 7.52B |
Retained Earnings | 10.31B | 10.31B | 10.37B | 10.64B | 10.04B |
Treasury Stock & Other | -7.38B | -6.84B | -6.85B | -6.84B | -6.91B |
Total Common Equity | 10.77B | 11.22B | 11.06B | 11.19B | 10.65B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 10.77B | 11.22B | 11.06B | 11.19B | 10.65B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 91.80M | 87.00M | 85.50M | 104.50M | 125.60M |
Total Equity | 10.86B | 11.31B | 11.15B | 11.29B | 10.78B |
|